TREX1 and neoplasm: Immune checkpoint blockade-specific polygenic scores (PICS) derived from TIME eQTLs implicated putative targets to modify anti-tumor immunity; TREX1 has previously been highlighted as a promising target73, and small molecule inhibition of CTSS resulted in slower tumor growth and longer survival of mice, with effects comparable to anti-PD-1.